Society Archives

Medgadget Exclusive: Interview about the Healthbots

nz healthbots Medgadget Exclusive: Interview about the Healthbots We are only two months into 2012 and it’s clear that the Quantified Self movement is increasingly gaining traction. More devices are emerging to help people quantify everything from anxiety to weight, and blood glucose to sleep patterns. But what about people who cannot use the devices or are not ambulatory themselves?

A team led by Professor Bruce MacDonald at the University of Auckland in New Zealand has been working to create a corp of medical robots – Healthbots – to help these people. Medgadget had the opportunity to interview Professor MacDonald about the Healthbots, what they do, and when we can expect to see them available to help those in need.

 

Shiv Gaglani, Medgadget: Please describe your implementation goal for the Healthbots.

Professor Bruce MacDonald: Our goal is to develop practical software technology for personal mobile robots, working together with our partners in South Korea who make the robot devices, the older care organization, The Selwyn Foundation, in New Zealand and several New Zealand companies who have interests in helping older people. The work involves important research: for example, how to make robots acceptable to older people, how to design and develop robot software that can easily be deployed and used in practice, and how to place robots in a care system that really helps and empowers older people and also care staff.  We have evaluated these robots over the last four years, including in three trials. In the next few years we hope to see robots starting to be used by older people; perhaps initially for entertainment this year or next year. By 2020, we would like to see robotic assistants in many older peoples’ homes and apartments in retirement villages and in the community, around the world, helping people by doing simple tasks and providing, empowering, and enriching interactions including connections to their friends, family and caretakers who are in other places. We think there are a number of roles for robots in older care, including a robot as a care assistant that does simple tasks to help staff, and a companion robot that provides entertainment, interactions, and connections to friends and family using its touch screen and its connection to the internet. For all this we need a very well designed and simple interface that many people can use. In our trials, people have told us that they would like internet technology delivered via the robot, because it is easier to use than a computer. Our goal is to put robots all around the world and the New Zealand government funding that supports our work is aimed at the export market for New Zealand companies.

 

Medgadget: What are the main obstacles that need to be overcome between now and the implementation goal?

MacDonald: We need to have robots interacting with a lot of people, and then improve what the robots do according to peoples’ feedback. We need to find ways to get robots in peoples’ homes on a wide scale, across our communities; that includes support for helping people use the robots. Currently there is little business infrastructure for selling and supporting robots across large markets around the world, and people are not used to having robots around.  We have shown that people will accept robots in older care, and that the robots can work in an elderly care environment. We are hoping our current studies will verify that robots improve the life experience of older people and their care staff.  The next step is to deploy robots in many places. Also we need to narrow the focus to some simple initial applications for the robots; so far we have many things that the robots can do.

Medgadget: What types of conditions in people are the Healthbots most suited to helping? For example, hypertension/CVD, diabetes, Alzheimer’s, etc?

MacDonald:   I think robots can help people with all kinds of conditions, by helping them manage the condition, and by enriching peoples’ lives with more interesting activities and interactions when the condition imposes limitations on what people can do by themselves. The medication management system on the robots is also important. Many older people are taking several medications several times a day and it can be a challenge to remember all the medications, the times they should be taken, and any limitations about each medications (e.g. with or without food or water). Some medications should be taken only if the older person has certain symptoms at the time. The robot system can remind people to take medications at the right time, and in the right way, and it can ask them about their symptoms and then remind them what to take as a result. Also the doctor seems to like receiving a weekly summary on a web page, of the medications taken, the vitals signs taken every time the medications are taken (e.g. blood pressure and heart rate), and some answer to a few symptom questions that the doctor can tell the robot to ask. So we think this can help people with any conditions that are managed by medications, and that includes many conditions, including hypertension/CVD (something we are working on with NZ company Pulsecor whose device measures arterial stiffness as well as blood pressure), diabetes (the robot can also collect blood glucose results), and respiratory problems that require inhaler use (something we are working on with NZ company Nexus6 who make devices to monitor inhaler use). We also think that the robot can help people with Alzheimer’s, however we are still evaluating how these people interact with robots like ours. For people with mild cognitive problems we think the robot will be useful for reminding them about their daily activities for example. And maybe the robot will help calm people with more severe dementia. We also think that our robots will help people who are socially isolated and lonely, because it will give them something to interact with, and also will enable them to communicate through the internet with their friends and family. We provided a simple Skype interface on our robot and that has been very popular; people often find Skype a little tricky to use and the robot simplifies that.  We are also developing ways for monitoring peoples’ daily movements, using wearable accelerometers, and we plan to use the robot to interact with people using the information collected.
Medgadget: Are there any other settings or populations that the Healthbots may be useful for (e.g. inpatients, children, etc)?

MacDonald: Yes, we think robots can help children who have autism and other conditions and we think that robots can help all kinds of people who have long term conditions, and people who are socially isolated for any reason. There is some research to show that children with autism can react quite positively to robots, and robots may have the potential to teach children social skills by providing a way for them to practice their skills with the robot. We think that robots can help people with disabilities, for example helping to remind people about their daily activities if they have cognitive problems and helping people to manage their medications if they take a lot of medication. The robot can also help link people with their doctors and caretakers, by managing all their health information, which is something we are working on with a NZ company Lifetime Health Diary.

 

TVNZ Segment on the recent Healthbot trial in New Zealand retirement homes…

University of Auckland’s Healthbots Media Centre…

Interview with QuantiaMD, the Largest Online Network of Physicians

Interview with QuantiaMD, the Largest Online Network of Physicians

Given all of the recent media buzz surrounding Facebook – the Emperor of all Social Networks – we at Medgadget wanted to reflect some of that light onto the social networks that are most influencing medicine today. One such network is QuantiaMD, whose membership exceeds 150,000 physicians, according to the company, or one in five in the US!

We have previously covered two apps developed by the company: DiabetesIQ and Pri-Med. This editor first met up with QuantiaMD’s CEO, Eric Schultz, and Chief Communications Officer, Mary Modahl, at the mHealth Summit and just touched base again to produce the interview below.

Read More

Patient Advocate on Quest to Get Data from His Implantable Defibrillator

Patient Advocate on Quest to Get Data from His Implantable Defibrillator

Venture Beat recently named the “Quantified Self” movement as a top trend for 2012. That publication defined the movement as “self-knowledge through numbers” and cited a number of gadgets that enable their users to quantify everyday activities such as workouts, sleep, heart rate, and galvanic skin response.

Hugo Campos is a proponent of this movement: He uses a FitBit device to keep track of his daily activity level, a Withings blood pressure monitor, a WiFi scale, and a Zeo sleep monitor. He cannot, however, access the data in his implantable cardiac defibrillator (ICD) because such data is off limits to patients. The data from his ICD can, however, be accessed by his physician and the device’s manufacturer.

Read More

Stanford Partners with FDA to Improve Pre-Market Approval Process

Stanford Partners with FDA to Improve Pre-Market Approval Process

Stanford’s decade old biodesign program is partnering up with FDA Center for Devices and Radiological Health to help the agency adapt the way it screens new medical technologies.

The parties have reached a “memorandum of understanding,” rather than a formal agreement to specific projects, but the framework creates a method by which cooperation can now take place.

Read More

FDA Issues Guidance to Companies Seeking Approval for Artificial Pancreas System

FDA Issues Guidance to Companies Seeking Approval for Artificial Pancreas System

The FDA has issued draft guidance to companies that are looking to submit an Investigational Device Exemption (IDE) or premarket approval (PMA) application for an Artificial Pancreas Device System that would be used by patients at home.

The document explains how one should go about proving the safety and effectiveness of an artificial pancreas, although the guidance is clear that these are simply recommendations and that “the word should in Agency guidances means that something is suggested or recommended, but not required.”

Read More

FDA Releases Blueprint for “Driving Biomedical Innovation”

FDA Releases Blueprint for "Driving Biomedical Innovation"

A report just released by the Commissioner of the Food & Drug Administration (FDA), Dr. Margaret Hamburg, aims to provide immediate steps to quicken biomedical innovation.

Entitled “Driving Biomedical Innovation: Initiatives to Improve Products for Patients,” the 37-page blueprint briefly touches upon a number of important topics, including how to build the infrastructure to drive and support personalized medicine as well as what the FDA anticipates to be the future of medical devices (e.g. in terms of regulation).

Read More

Successful Remote Hacking Reported of Insulin Pump, Glucose Meters

Successful Remote Hacking Reported of Insulin Pump, Glucose Meters

Though most would agree that the digitization of our daily lives has overall been positive, there remains the persistent danger posed by hackers. This risk has ranged from the fairly innocuous (e-mail or Facebook spammers) to the financially ruinous (online bank account and credit card theft), and sometimes even to seizure inducing. However, with the digitization of medical devices – a trend that often awes us by its potential to improve healthcare delivery – the danger associated with hacking may now even be deadly.

At last week’s Black Hat Technical Security Conference, computer security expert and type 1 diabetic Jerome Radcliffe gave a presentation in which he described how he was able to remotely interfere with his own insulin pump and glucose meter.

Read More

Institute of Medicine to Release Controversial Report on Medical Device Approval on Friday

Institute of Medicine to Release Controversial Report on Medical Device Approval on Friday

The New York Times just recently broke news of the coming controversy surrounding an Institute of Medicine report on the medical device industry that will be released this Friday.

Commissioned by the Food & Drug Administration in response to the apparent increase in medical device recalls due to failures and patient injuries over recent years, the report is expected to propose more stringent industry-wide regulations such as tougher approval processes for devices such as defibrillators, hip implants, and hospital pumps. The specific focus of the report is on the 510(k) Medical Device Clearance Process.

Read More

FDA to Exercise Its Muscle in the Mobile App Arena

FDA to Exercise Its Muscle in the Mobile App Arena

Medical applications have played a significant role in the rapid adoption of smartphones and tablets, but to date, we’ve only covered two apps which were reviewed by the FDA prior to their public release (Mobile MIM, pictured, and AirStrip). However, the FDA announced yesterday that it plans to regulate mobile apps which would be used by doctors to diagnose or monitor their patients. The FDA released draft guidelines on its website and will be taking comments for the next 3 months.

More from the FDA:

Read More